0001463972 false 0001463972 2021-03-17 2021-03-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) March 17, 2021

 

VUZIX CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

001-35955 04-3392453
(Commission File Number) (IRS Employer Identification No.)

 

25 Hendrix Road, Suite A

West Henrietta, New York 14586

(Address of principal executive offices)(Zipcode)

 

(585) 359-5900

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
Common Stock, par value $0.001   VUZI   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 17, 20201 Vuzix Corporation (the “Company”) granted options to purchase 1,750,000 shares of common stock to Grant Russell, the Company’s chief financial officer, and options to purchase 3,260,000 shares of common stock to Paul Travers, the Company’s chief executive officer. The options are being granted under the Company’s existing 2014 Incentive Stock Plan. The options have an exercise price of $19.00. 125,000 of Mr. Russell’s options and 250,000 of Mr. Travers’ options vest immediately and the remainder will vest upon achievement of certain market capitalization and operating results goals and not simply the passage of time, as follows:

 

Award Potential     Criteria Achievement Weighting  
            50%     35%     15%  
Options:
Travers
    Options:
Russell
    Equity Market
Capitalization
Threshold
    Revenue Target    

EBITDA Margin

before Non-Cash

Charges Target

 
  250,000       125,000     $ 1,000,000,000       N/A       N/A  
  400,000       200,000       2,000,000,000     $ 25,000,000       0.0 %
  400,000       200,000       3,000,000,000       50,000,000       2.0 %
  400,000       200,000       4,000,000,000       100,000,000       4.0 %
  400,000       200,000       5,000,000,000       200,000,000       6.0 %
  325,000       175,000       6,000,000,000       300,000,000       8.0 %
  325,000       175,000       7,000,000,000       450,000,000       10.0 %
  300,000       175,000       8,000,000,000       675,000,000       12.0 %
  230,000       175,000       9,000,000,000       1,000,000,000       14.0 %
  230,000       125,000       10,000,000,000       1,500,000,000       16.0 %
  3,260,000       1,750,000                          

 

The Company also granted to other management employees options to purchase an aggregate of 990,000 shares of common stock with an exercise price of $19.00 and similar vesting terms. Re-sale of the shares issuable upon exercise of the options granted to Mr. Travers, Mr. Russell and other management employees will be subject to certain restrictions for up to 24 months, which will be removed on a monthly basis over such 24 month period.

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 19, 2021 VUZIX CORPORATION
     
  By:   /s/ Grant Russell
    Grant Russell
    Chief Financial Officer